期刊文献+

2型糖尿病患者血清肿瘤坏死因子-α、瘦素和可溶性血管内皮细胞黏附因子1水平与心脑血管并发症的相关性 被引量:9

Relations of levels of tumor necrosis factor-α,leptin,soluble vascular cell adhesion molecule-1 in blood serum to cardio-cerebrovascular complications for type 2 diabetes mellitus patients
暂未订购
导出
摘要 目的探讨肿瘤坏死因子-α(TNF-α)、瘦素、可溶性血管内皮细胞黏附分子1(sVCAM-1)水平在2型糖尿病(T2DM)患者血清中的变化及其与T2DM心脑血管并发症的相关性。方法选择健康体检者30例为对照组,T2DM患者34例为糖尿病组,T22DM合并心脑血管病变者41例为并发症组。采用双抗体夹心法酶联免疫吸附试验检测各组患者血清TNF-α、瘦素和sVCAM-1水平;采用全自动血生化分析仪和化学发光法分别检测各组患者空腹血清葡萄糖(FPG)和空腹血清胰岛素(FINS)水平,采用稳态模型评估法(HOMA)计算胰岛素抵抗指数(HOMA-IR)。结果糖尿病组、并发症组血清TNF-α、瘦素和sVCAM-1水平及HOMA-IR均显著高于对照组,差异有统计学意义(P<0.01);糖尿病组和并发症组间各指标比较差异均有统计学意义(P<0.01)。糖尿病组、并发症组TNF-α、瘦素和sVCAM-1水平与HOMA-IR成正相关(r=0.452、0.489、0.442、0.476、0.569、0.572,P<0.05),并发症组TNF-α、瘦素、sVCAM-1与HOMA-IR的相关系数均高于糖尿病组TNF-α、瘦素、sVCAM-1与HOMA-IR的相关系数。结论 TNF-α、瘦素和sVCAM-1是T2DM及其心脑血管并发症发生发展的高危因素;TNF-α、瘦素和sVCAM-1与T2DM胰岛素抵抗明显相关。 Objective To investigate the changes of tumor necrosis factor-α(TNF-α),leptin,soluble vascular cell adhesion molecule-1(sVCAM-1)levels in blood serum of patients with type 2 diabetes mellitus(T2DM) and the relations between the three index and cardio-cerebrovascular complications.Methods Thirty healthy people who had medical examination were chosen as control group,34 patients with T2DM were chosen as diabetes group and 41 patients with T2DM and cardio-cerebrovascular diseases were chosen as complication group.A double antibody sandwich enzyme-linked immunosorbent assay was used to detect the levels of TNF-α,leptin,sVCAM-1 in blood serum of the subjects.Automatic blood biochemical analyzer and chemiluminescence method were used respectively to detect the contents of fasting serum glucose(FPG)and fasting serum insulin(FINS)of the subjects,and insulin resistance(IR)index was estimated by homeostasis model assessment(HOMA).Results The levels of TNF-α,leptin,sVCAM-1 and HOMA-IR of the diabetes group and complication group were significantly higher than those in control group,the differences were statistically significant(P〈0.01).There were significant differences in above indexes between diabetes group and complication group(P〈0.01).The levels of TNF-α,leptin and sVCAM-1 had significant positive correlation with HOMA-IR in diabetes group and complication group(r=0.452,0.489,0.442,0.476,0.569,0.572,P〈0.05),and all the correlation coefficients in complication group were higher than those in diabetes group.Conclusion TNF-α,leptin and sVCAM-1 are high risk factors for T2DM and its cardiovascular and cerebrovascular complications development,and the 3 indexes are significantly correlated with IR of T2DM.
作者 宿建丽 王静
出处 《新乡医学院学报》 CAS 2013年第4期292-294,共3页 Journal of Xinxiang Medical University
关键词 2型糖尿病 胰岛素抵抗 肿瘤坏死因子-Α 瘦素 可溶性血管内皮细胞黏附分子1 type 2 diabetes mellitus insulin resistance tumor necrosis factor-α leptin soluble vascular cell adhesion molecule-1
  • 相关文献

参考文献10

  • 1Barzilay J I, Abraham L, Heckbert S R, et al. Ttle ralation of mark- ers of inflammation to the development of glucose disorders in the elderly : the cardiovascular health study [ J ]. Diabetes, 2001,50 (6) :2384-2389.
  • 2户富栋,高娟,王祥.心血管病新危险因素研究进展[J].新乡医学院学报,2011,28(1):123-126. 被引量:9
  • 3Matsuura H. Prehypertension and metabolic syndrome:Prevention of hypertension and cardiovascular events [ J ]. Hypertens Res, 2008,31 (7) : 1275-1276.
  • 4Lu L, Pu L J, Xu X W, et al. Association of serum levels of glycated albumin, C-reactive protein and tumor necrosis factor-alpha with the severity of coronary artery disease and renal impairment in pa- tients with type 2 diabetes mellitus [ J ]. Clin Biochem, 2007,40 (11) :810-816.
  • 5Zhang Y, Proenea R, Mallei M, et al. Positional cloning of them ouseobese gene and its human homologue [ J]. Nature, 1994,372 (6505) :425-432.
  • 6郭启煜,高妍.瘦素与胰岛素抵抗[J].国外医学(内分泌学分册),2002,22(5):313-316. 被引量:17
  • 7Boer-Martins L, Figueiredo V N, Demacq C, et al. Leptin and aldo- sterone in sympathetic activity in resistant hypertension with or without type 2 diabetes [ J ]. Arq Bras Cardiol, 2012,99 ( 1 ) : 642- 648.
  • 8Krasnodebski P, Bak M I, Opolski G,et al. Leptin in acute myocar- dial infarction and period of convalescence in patients with type 2 diabetes mellitus [ J]. Kardiol Po1,2010,68 (6) :648-653.
  • 9Apple F S, Wu A H, Mair J, et al. Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome[ J ]. Clin Chem,2005 ,51 (5) :810-824.
  • 10Monaco C,Andreakos E. T cell-mediated sinaling to vascular en- dothelium:induction of cytokines chemokines and tissue factor [ J ]. J Leukoc Bio1,2002,71 (4) :659 -668.

二级参考文献28

  • 1Stoll G, Bendszus M. Inflammation and atherosclerosis: novel insights into plaque formation and destabilization [ J ]. Stroke, 2006, 37 ( 7 ) : 1923-1932.
  • 2Danesh J, Kaptoge S, Mann A G, et al. Long-term interleukin45 levels and subsequent risk of coronary heart disease : two new prospective studies and a systematic review [ J ]. PLoS Med, 2008,5 (4) : e78.
  • 3Hsieh M J,Chen C C ,Lee T H ,et al. Metabolic syndrome and homocysteine level as predictors of the severity of coronary artery disease in patients with carotid stenosis[ J ]. Am J Med Sci,2009, 338(6) :447-452.
  • 4Panagiotakos D B, Pitsavos C ,Zeimbekis A ,et al. The association between lifestyle-related factors and plasma homocysteine levels in healthy individuals from the " ATFICA" Study[ J]. Int J Cardiol,2005,98 ( 3 ) :471-477.
  • 5Stassen F R, Vainas T, Bruggeman C A. Infection and atherosclerosis. An alternative view on an outdated hypothesis[ J]. Pharmacol Rep,2008,60( 1 ) :85-92.
  • 6Hunt K J, Resendez R G, Williams K,et al. National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in tile San Antonio Heart Study [ J ]. Circulation, 2004, 110 ( 10 ) : 1251-1257.
  • 7Lincoff A M,Wolski K,Nieholls S J,et al. Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus:a meta-analysis of randomized trials [ J ]. JAMA, 2007,298 ( 10 ) : 1180-1188.
  • 8Nissen S E, Wolski K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes [ J]. N Engl J Med,2007 ,356( 24 ) :2457-2471.
  • 9Bado A,Levasseur S,Attoub S,et al.The stomach is a source of leptin[J].Nature,1998,394:790-793.
  • 10Wang J,Liu R,Hawkins M,et al.A nutrient-sensing pathway regulates leptin gene expression in muscle and fat[J].Nature,1998,393:684-688.

共引文献24

同被引文献88

引证文献9

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部